PharmaTher Holdings EBIT

PharmaTher Holdings (PHRRF) currently reports a EBIT of $-850K as of May 2026. That compares with $-1.5M in the prior-year period — up 45.4% year over year. That is below the Healthcare sector average of $130B. Use the charts on this page to explore PharmaTher Holdings's EBIT history and peer comparisons.

PharmaTher Holdings's EBIT increased from $-1.5M to $-850K — a 45.4% year-over-year increase (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PharmaTher Holdings's EBIT of $-850K is lower than the Healthcare sector average of $130B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

PharmaTher Holdings reported $-850K in EBIT as of May 2026. That compares with $-1.5M in the prior-year period — up 45.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-850K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $130B. From there, open related valuation or income-statement pages for PharmaTher Holdings, and consider following PHRRF for alerts when major investors trade the stock.